- Home
- OSPR vs CLPT Comparison
OSPR vs CLPT Comparison
Compare OSPR & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OSPR | CLPT |
|---|---|---|
| Founded | 2026 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 403.2M | 467.9M |
| IPO Year | 2026 | 2009 |
Fundamental Metrics
Financial Performance| Metric | OSPR | CLPT |
|---|---|---|
| Price | $9.83 | $8.64 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 156.4K | ★ 647.3K |
| Earning Date | N/A | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $31.18 |
| Revenue Next Year | N/A | $15.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $9.76 | $8.27 |
| 52 Week High | $9.89 | $19.63 |
Technical Indicators
Market Signals| Indicator | OSPR | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 51.88 | 34.72 |
| Support Level | $9.80 | N/A |
| Resistance Level | $9.86 | $11.93 |
| Average True Range (ATR) | 0.01 | 0.75 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 75.00 | 7.01 |
Price Performance
Historical ComparisonAbout OSPR Osprey Acquisition Corp. III Class A Ordinary Shares
Osprey Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.